Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase... von Feagan, Brian G, Prof, Sandborn, William J, MD, D'Haens, Geert, Prof, Panés, Julián, Prof, Kaser, Arthur, Prof, Ferrante, Marc, Prof, Louis, Edouard, Prof, Franchimont, Denis, Prof, Dewit, Olivier, Prof, Seidler, Ursula, Prof, Kim, Kyung-Jo, Prof, Neurath, Markus F, Prof, Schreiber, Stefan, Prof, Scholl, Paul, MB BChir, Pamulapati, Chandrasena, PhD, Lalovic, Bojan, PhD, Visvanathan, Sudha, PhD, Padula, Steven J, MD, Herichova, Ivona, PhD, Soaita, Adina, PhD, Hall, David B, PhD, Böcher, Wulf O, Prof

Volltext

Long‐term efficacy of tenofovir monotherapy for hepatitis B virus‐monoinfected patients after failure of nucleoside/nucleotide analogues von van Bömmel, Florian, de Man, Robert A., Wedemeyer, Heiner, Deterding, Katja, Petersen, Jörg, Buggisch, Peter, Erhardt, Andreas, Hüppe, Dietrich, Stein, Kerstin, Trojan, Jörg, Sarrazin, Christoph, Böcher, Wulf O., Spengler, Ulrich, Wasmuth, Hermann E., Reinders, Jurrien G.P., Möller, Bernd, Rhode, Peter, Feucht, Heinz‐Hubert, Wiedenmann, Bertram, Berg, Thomas

Volltext

Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study von Feagan, Brian G, Panés, Julián, Ferrante, Marc, Kaser, Arthur, D'Haens, Geert R, Sandborn, William J, Louis, Edouard, Neurath, Markus F, Franchimont, Denis, Dewit, Olivier, Seidler, Ursula, Kim, Kyung-Jo, Selinger, Christian, Padula, Steven J, Herichova, Ivona, Robinson, Anne M, Wallace, Kori, Zhao, Jun, Minocha, Mukul, Othman, Ahmed A, Soaita, Adina, Visvanathan, Sudha, Hall, David B, Böcher, Wulf O

Volltext

Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial von Sulkowski, Mark S., Asselah, Tarik, Lalezari, Jacob, Ferenci, Peter, Fainboim, Hugo, Leggett, Barbara, Bessone, Fernando, Mauss, Stefan, Heo, Jeong, Datsenko, Yakov, Stern, Jerry O., Kukolj, George, Scherer, Joseph, Nehmiz, Gerhard, Steinmann, Gerhard G., Böcher, Wulf O.

Volltext

Faldaprevir combined with peginterferon alfa‐2a and ribavirin in chronic hepatitis C virus genotype‐1 patients with prior nonresponse: SILEN‐C2 trial von Sulkowski, Mark S., Bourlière, Marc, Bronowicki, Jean‐Pierre, Asselah, Tarik, Pawlotsky, Jean‐Michel, Shafran, Stephen D., Pol, Stanislas, Mauss, Stefan, Larrey, Dominique, Datsenko, Yakov, Stern, Jerry O., Kukolj, George, Scherer, Joseph, Nehmiz, Gerhard, Steinmann, Gerhard G., Böcher, Wulf O.

Volltext

Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir von BERGER, Kristi L, TRIKI, Ibtissem, KUKOLJ, George, CARTIER, Mireille, MARQUIS, Martin, MASSARIOL, Marie-Josée, BÖCHER, Wulf O, DATSENKO, Yakov, STEINMANN, Gerhard, SCHERER, Joseph, STERN, Jerry O

Volltext

Fecal MicroRNAs Show Promise as Noninvasive Crohn's Disease Biomarkers von Wohnhaas, Christian T, Schmid, Ramona, Rolser, Marcel, Kaaru, Eric, Langgartner, Dominik, Rieber, Kathrin, Strobel, Benjamin, Eisele, Claudia, Wiech, Franziska, Jakob, Ines, Gantner, Florian, Herichova, Ivona, Vinisko, Richard, Böcher, Wulf O, Visvanathan, Sudha, Shen, Fei, Panzenbeck, Mark, Raymond, Ernest, Reber, Stefan O, Delić, Denis, Baum, Patrick

Volltext

Selective IL-23 Inhibition by Risankizumab Modulates the Molecular Profile in the Colon and Ileum of Patients With Active Crohn's Disease: Results From a Randomised Phase II Biopsy... von Visvanathan, Sudha, Baum, Patrick, Salas, Azucena, Vinisko, Richard, Schmid, Ramona, Grebe, Kristie M, Davis, Justin W, Wallace, Kori, Böcher, Wulf O, Padula, Steven J, Fine, Jay S, Panés, Julián

Volltext

ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection von Asselah, Tarik, Zeuzem, Stefan, Soriano, Vicente, Bronowicki, Jean-Pierre, Lohse, Ansgar W, Müllhaupt, Beat, Schuchmann, Marcus, Bourlière, Marc, Buti, Maria, Roberts, Stuart K, Gane, Edward J, Stern, Jerry O, Voss, Florian, Baum, Patrick, Gallivan, John-Paul, Böcher, Wulf O, Mensa, Federico J

Volltext

Mechanisms underlying benign and reversible unconjugated hyperbilirubinemia observed with faldaprevir administration in hepatitis C virus patients von Sane, Rucha S, Steinmann, Gerhard G, Huang, Qihong, Li, Yongmei, Podila, Lalitha, Mease, Kirsten, Olson, Stephen, Taub, Mitchell E, Stern, Jerry O, Nehmiz, Gerhard, Böcher, Wulf O, Asselah, Tarik, Tweedie, Donald

Volltext

Vitamin D levels vary during antiviral treatment but are unable to predict treatment outcome in HCV genotype 1 infected patients von Grammatikos, Georgios, Lange, Christian, Susser, Simone, Schwendy, Susanne, Dikopoulos, Nektarios, Buggisch, Peter, Encke, Jens, Teuber, Gerlinde, Goeser, Tobias, Thimme, Robert, Klinker, Hartwig, Boecher, Wulf O, Schulte-Frohlinde, Ewert, Penna-Martinez, Marissa, Badenhoop, Klaus, Zeuzem, Stefan, Berg, Thomas, Sarrazin, Christoph

Volltext

Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results von ZEUZEM, Stefan, ASSELAH, Tarik, BRONOWICKI, Jean-Pierre, ROBERTS, Stuart, ARASTEH, Keikawus, ZOULIM, Fabien, HEIM, Markus, STERN, Jerry O, NEHMIZ, Gerhard, KUKOLJ, George, BÖCHER, Wulf O, MENSA, Federico J, ANGUS, Peter, ZARSKI, Jean-Pierre, LARREY, Dominique, MÜLLHAUPT, Beat, GANE, Ed, SCHUCHMANN, Marcus, LOHSE, Ansgar W, POL, Stanislas

Volltext

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection von Manns, Michael P, Bourlière, Marc, Benhamou, Yves, Pol, Stanislas, Bonacini, Maurizio, Trepo, Christian, Wright, David, Berg, Thomas, Calleja, José L, White, Peter W, Stern, Jerry O, Steinmann, Gerhard, Yong, Chan-Loi, Kukolj, George, Scherer, Joe, Boecher, Wulf O

Volltext

Near-Optimal Low-Complexity Harmonic Receiver for Unipolar-FSK von Azim, A. W., Khan, M. J., De Wulf, O., Le Guennec, Y., Maury, G., Ros, L.

Volltext

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-α2b and ribavirin in patients with HBV/HCV co-infection von Potthoff, Andrej, Wedemeyer, Heiner, Boecher, Wulf O, Berg, Thomas, Zeuzem, Stefan, Arnold, Joachim, Spengler, Ulrich, Gruengreiff, Kurt, Kaeser, Thomas, Schuchmann, Marcus, Bergk, Alexandra, Forestier, Nicole, Deterding, Katja, Manns, Michael P, Trautwein, Christian

Volltext

All-trans retinoic acid for treatment of chronic hepatitis C von Böcher, Wulf O., Wallasch, Christian, Höhler, Thomas, Galle, Peter R.

Volltext

Efficacy and Safety of Open-Label Maintenance Therapy with Subcutaneous Risankizumab in Patients with Moderateto-Severe Crohn's Disease von Feagan, Brian G, Panes, Julian, Ferrante, Marc, Kaser, Arthur, D'Haens, Geert R, Sandborn, William J, Louis, Edouard, Neurath, Markus, Franchimont, Denis, Dewit, Olivier, Seidler, Ursula, Kim, Kyung-Jo, Selinger, Christian, Padula, Steven J, Herichova, Ivona, Robinson, Anne M, Wallace, Kori, Zhao, Jun, Soaita, Adina, Visvanathan, Sudha, Hall, David, Böcher, Wulf O

Volltext

812a Efficacy and Safety of Induction Therapy With the Selective IL-23 Inhibitor BI 655066, in Patients With Moderate-to-Severe Crohn's Disease: Results of a Randomized, Double-Bli... von Feagan, Brian G, Sandborn, William, Panés, Julian, Ferrante, Marc, Louis, Edouard, D'Haens, Geert R, Franchimont, Denis, Kaser, Arthur, Dewit, Olivier, Seidler, Ursula, Kim, Kyung-Jo, Neurath, Markus, Scholl, Paul, Visvanathan, Sudha, Padula, Steven, Herichova, Ivona, Soaita, Adina, Hall, David, Böcher, Wulf O

Volltext

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials von Jensen, Donald M, Asselah, Tarik, Dieterich, Douglas, Foster, Graham R, Sulkowski, Mark S, Zeuzem, Stefan, Mantry, Parvez, Yoshida, Eric M, Moreno, Christophe, Ouzan, Denis, Wright, Mark, Morano, Luis E, Buynak, Robert, Bourlière, Marc, Hassanein, Tarek, Nishiguchi, Shuhei, Kao, Jia-Horng, Omata, Masao, Paik, Seung W, Wong, David K, Tam, Edward, Kaita, Kelly, Feinman, S. Victor, Stern, Jerry O, Scherer, Joseph, Quinson, Anne-Marie, Voss, Florian, Gallivan, John-Paul, Böcher, Wulf O, Ferenci, Peter

Volltext

Activation of dendritic cells by local ablation of hepatocellular carcinoma von Ali, Mona Y., Grimm, Christian F., Ritter, Marcus, Mohr, Leonhard, Allgaier, Hans-Peter, Weth, Robert, Bocher, Wulf O., Endrulat, Katja, Blum, Hubert E., Geissler, Michael

Volltext